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ABSTRACT 
Various cell types in the intestinal mucosa are constantly exposed to complex signals 
emanating from the lumen, including the microbiota and its metabolites. How these bilateral 
interactions in turn influences intestinal homeostasis is an important question in order to 
understand microbiota-host interactions. This thesis has attempted to address this question in 
the following papers. Deletion of the diet- and microbiota-regulated aryl hydrocarbon 
receptor in CD11c+ cells was found to result in aberrant intestinal epithelium morphogenesis 
and increased susceptibility of these mice to chemically induced colitis (Paper I). Our data 
highlight a possible gateway of communication between the host and its environment, 
through the AhR in intestinal antigen presenting cells, consequently regulating intestinal 
epithelial cell biology and function.  
In the second paper, we studied the impact of the microbiota on the development of the 
enteric nervous system (ENS). The ENS controls many aspects of gut physiology, including 
mucosal immunity. The major cellular component of the ENS is the enteric glia cell (EGC). 
Our data showcased that the migration and expansion of EGC networks in the lamina propria 
towards the lumen are under the influence of the microbiota. The postnatal expansion of 
mucosal EGC networks was found to coincide with the same period where the microbiota 
increases in number and diversity. Moreover, this microbiota-driven mechanism is an active 
process that can be impaired following the exposure to antibiotics, which abrogate signalling 
pathways mediating the host-microbe cross talk.  
In the final manuscript, we developed a co-culture model system to study EGC functions 
further, in relation to intestinal epithelial barrier functions. Using genetic labeling techniques 
and live cell imaging, we observed close associations of EGCs with co-cultured intestinal 
epithelial organoids ex vivo, reminiscent of the contacts reported between these two cell types 
in vivo.   
In conclusion, this thesis open more questions than answers especially as it addresses the 
issue of cross communication between different biological systems required for the 
development of complex organisms. The new player here is the microbiome and how it 
constantly affects the response of different cell types, including cell-to-cell communications, 
important for cellular adaptation to environmental cues. Future work will address the precise 
molecular and cellular mechanisms underlying the interplay between the microbiota and host-
tissues to establish and maintain intestinal homeostasis.  
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1 INTRODUCTION 
1.1 OVERVIEW 
The primary function of the gastrointestinal (GI) tract is to digest our daily food and for the 
absorption of nutrients. For this purpose, the GI tract has employed several biological systems 
to enable it to carry out these functions. First, the luminal surfaces are lined with a single 
layer of epithelial cells that constitutes the intestinal epithelial barrier (IEB), forming the 
major absorptive organ in the GI tract, in addition to separating us (the host) from its resident 
microbiota. Second, a huge proportion of our body’s immune cells can be found underlying 
the mucosal surfaces of the intestines where they play crucial roles in driving oral tolerance 
and immunity against potential pathogens. Third, our intestine is immensely innervated with 
inputs from the central nervous system (CNS) in addition to having its own ‘brain’ - the 
Enteric Nervous System (ENS) that controls various aspects of GI functions, including 
peristalsis. Lastly, our GI tract is also the platform for exchange between the host and its 
external environment (the gut lumen) regardless of being inside of the body, as illustrated by 
our interaction with the resident microbiota. For reasons mentioned here, I have dedicated a 
huge part of my Ph.D. studies in trying to understand the interconnection between these 
different biological systems/platforms and how environmental factors can perturb the normal 
physiological interactions between them, leading to disease.  
In order to respond to the dynamic environment, it is necessary to develop sensing 
mechanisms that upon exposure to extrinsic signals allow a cell to react and adapt quickly. To 
do this, cells need to regulate the expression of genes reciprocally to these signals in order to 
maintain their competitive advantage. Ligand-induced transcription factors are a class of 
structurally unrelated proteins that upon ligand activation, binds to the promoters and/or 
enhancer sequences of target genes to regulate transcription. In this manner, these factors are 
best-fit for acting as environmental sensors since they are able to modulate the expression of 
genes in a signal (ligand)-dependent way, thus supporting cells to respond to environmental 
cues rapidly. One such pathway of sensing and activation is the aryl hydrocarbon receptor  
(AhR) signalling pathway, which is studied in conjunction with intestinal antigen presenting 
cells (APCs) in the first part of this thesis.  
The mucosal immune system is comprised of elements from the gut-associated lymphoid 
tissues (GALT) such as the Peyer’s patches, isolated lymphoid follicles and mesenteric 
lymph nodes (mLN) while immune cells can also be found throughout the mucosa lamina 
propria. Intestinal APCs are seen as the sentinel cells that coordinate both innate and adaptive 
immune responses, important for tolerance and immunity through the use of receptors that 
identify pathogens, coined as pathogen recognition receptors (PRRs). Recently, the AhR (as 
mentioned above) has been proposed to be one of the PRRs1, supporting a role for AhR in 
intestinal APCs and immunity.   
To begin, I will first introduce the AhR, followed by overviews of the roles of different 
biological systems in GI tract functions, with references to AhR where applicable.  
 2 
1.2 ARYL HYDROCARBON RECEPTOR BIOLOGY 
The AhR is highly evolutionary conserved with homologues found in organisms for instance, 
in C. elegans and D. melanogaster apart from mammals2. This highlights the involvement of 
AhR signalling in fundamental biological processes critical for the well-being of complex 
organisms. We will introduce the canonical signalling pathway of the AhR.  
1.2.1 Signalling pathways of the AhR 
The AhR is a ligand-activated transcription factor and a member of the basic Helix-Loop-
Helix/Per-Arnt-Sim (bHLH/PAS) family of proteins. It is expressed in many different cell 
types albeit at different levels. In the absence of a ligand, the inactive AhR is localised in the 
cytoplasm as a multi-protein complex. The complex consists of the AhR, heat shock protein 
90 (Hsp90) dimer, co-chaperon p23 as well as the XAP2 protein3-5. Upon ligand binding, 
exposure of the N-terminal nuclear localization signal of AhR as a result of ligand binding-
dependent conformational changes leads to the translocation of AhR and its cytosolic 
associated proteins into the nucleus. Once in the nucleus, the AhR nuclear translocator 
(ARNT) which is also a member of the bHLH/PAS family dimerizes with AhR and during 
that process uncouples AhR from its chaperons. The heterodimer of AhR and ARNT 
constitutes a functional transcription factor that binds to specific enhancer sequences 
commonly known as the xenobiotic response elements (XREs or dioxin response elements 
DREs) found upstream of AhR responsive genes. Mechanisms of transcriptional regulation 
are very similar to classical pathways given that AhR dependent signalling has been shown to 
rely on an array of common co-activators such as the p300 and the SRC protein6,7. The 
functional domains of the AhR protein with indicated regions showing their role, for 
example, in DNA binding or ligand binding are shown below (Figure 1).   
 
 
Figure 1. Functional domains of the AhR protein. By Jeff Dahl [CC BY-SA 4.0 
(http://creativecommons.org/licenses/by-sa/4.0)], via Wikimedia Commons. 
https://upload.wikimedia.org/wikipedia/commons/e/e2/AHR_functional_domains.svg 
As with all biological systems, negative feedback is essential and therefore the AhR 
signalling pathway is not an exception. Down-regulation of AhR signalling can be ascribed to 
two key mechanisms: (1) Degradation of AhR via the ubiquitin-proteosome pathway8 upon 
export out of the nucleus; (2) Attenuation of signalling via AhR repressor (AhRR), another 
bHLH/PAS family member9. Being structurally related to the AhR, the AhRR competes 
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effectively against AhR for ARNT in the nucleus without ligand binding and thus exerts its 
repressive effects on AhR regulated genes. The AhRR has been shown to be expressed at 
high levels upon AhR activation9 due to the binding of AhR:ARNT on XREs found upstream 
of AHRR promoter thereby provisioning the negative feedback loop.  
The sequence of events upon ligand binding to AhR in the cytosol as illustrated is only one 
out of the many other possible signalling pathways that have been described in the literature. 
Of note, AhR signalling can be activated independently of a ligand, through phosphorylation 
mediated by a second messenger: cAMP10. In addition, direct cross talk with transcription 
factors such as NF-kb, retinoblastoma protein, estrogen receptor and protein kinase pathways 
have also been reported11. In turn, these interactions afforded AhR the ability to influence a 
myriad of cellular processes such as cell proliferation and differentiation, vascular 
development and more, in a cell/tissue type specific manner.  
More recently, the AhR pathway has been implicated in development, tissue regeneration and 
cancer, through its interaction with β catenin/Wnt signalling pathway12-14. Corroboratively, 
the activation of Wnt signalling was found to increase the transcription of Ahr in at least three 
different cellular contexts15-17. Nonetheless, the exact mechanisms linking the two pathways 
are currently unclear as AhR activation could modulate Wnt signalling in both directions (up 
or down) as summarised in a recent review12. For this thesis the scope of the investigation is 
not on the various pathways/effects mentioned, excellent reviews for further analysis of the 
diversity in AhR signalling can be found in the literature11,18-20.  
1.2.2 Toxicity, Xenobiotics and Natural Ligands   
In the early days, AhR activation is thought to be largely dependent on the binding of 
environmental contaminants. For example non-halogenated polycyclic aromatic 
hydrocarbons and halogenated aromatic hydrocarbons are the most common, thus giving the 
receptor its name. Among these, the most well-studied environmental pollutant that elicits 
AhR-mediated toxicity is the 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD or dioxin). Since 
the 1980s, dioxin toxicity in animals has been widely documented which include but not 
limited to wasting, lymphoid involution, hepatotoxicity, epidermal changes (chloracne), 
gastric lesions, teratogenicity and endocrine effects21.   
The AhR activating potential of ligands can be easily examined by studying for the up-
regulation of well characterized AhR responsive genes such as xenobiotic metabolizing 
enzymes of the cytochrome P450 family: CYP1A1, CYP1A2 and CYP1B1 as well as its 
repressor AhRR. For this reason, many believed initially that the putative function of the AhR 
was to sense xenobiotics and subsequently up-regulate the expression of phase I and II 
enzymes to facilitate the excretion of these foreign chemicals from the body. However, the 
hypothesis was not sufficient in explaining the toxic effects caused by dioxin exposure. The 
half-life of dioxin in rodents is around 2 weeks, while in humans is estimated to be about 7 
years22. Thus, the persistence of dioxin within the body could theoretically result in the over-
activation of AhR, leading to either the up or down regulation of AhR responsive genes over 
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long periods of time. In this aspect, it is plausible to think that dioxin-mediated toxicity was 
due to the over or under activity of AhR responsive genes per se. Interestingly, sensitivity to 
dioxins and its toxic effects were found to be variable between species or even within the 
same species23. Taken together, it is unlikely for organisms to retain the Ahr gene through 
evolution just for the sensing of xenobiotics in the environment. A more logical hypothesis 
would be that lessons learned from toxicological studies were a reflection of normal 
physiological responses becoming disorganised as a consequence of persistent activation of 
the AhR by environmental pollutants. In other words, independent of mediating dioxin-
related toxicity effects, the AhR has in its own, biological relevance in the proper functioning 
of whole organisms.  
Only recently, investigators embarked on the search for promising endogenous and 
environmentally-derived AhR ligands24,25, including polycyclic compounds commonly found 
in our diet26,27. Examples include but not restricted to tryptophan (Trp) metabolites such as 
kynurenine (Kyn) and 6-formylindolo [3,2-b] carbazole (FICZ); indoles such as indole-3-
carbinol (I3C) found in cruciferous vegetables; Indigoids as well as arachidonic acid 
metabolites. Of interest, bacteria themselves (Lactobacillus bulgaricus OLL1181) can act as 
activators of the AhR pathway28. However, whether the strain of bacteria involved secretes 
enzymes that convert intestinal tryptophan to AhR ligands or it secretes AhR ligands directly 
remain to be elucidated. In support of the former, Lactobacillus reuteri in the presence of 
high Trp but low levels of carbohydrates has been shown to express high levels of ArAT-
related aminotransferase, which is involved in the production of indole-3-aldehyde, a reported 
AhR ligand29. Taken together, it is conceivable that high concentrations of AhR activating 
ligands exists in the GI tract (Figure 2).  
With the identification of putative endogenous AhR ligands in addition to the knowledge 
gained from studying the toxicity effects of AhR over-activation, evidence supporting its 
physiological functions became notable. Following, efforts in understanding the role of AhR 
signalling in immunology gained great momentum in recent years30,31. This is not surprising 
given that some of the most evident toxic effects of dioxin in animals were thymus involution 
and immuno-suppression in general. In the following chapter, I will provide some recent 
evidences supporting the critical role played by AhR, mainly in mucosal immunity.    
1.2.3 AhR in intestinal immune homeostasis 
Apart from well-recognized immune-toxic effects caused by dioxin exposure, numerous high 
profile reports confirmed the involvement of the AhR in regulating immune functions. One of 
the key discoveries was based on human hematopoietic stem cells where treatment with AhR 
antagonists promoted their expansion ex vivo32.  In support for the role of AhR in the immune 
system, cell types from both the innate and adaptive divisions of the immune system were 
discovered to express high levels of AhR33. However, the exact mechanisms behind AhR-
dependent modulation of the immune system and its constituents (various immune cell types) 
remain to be elucidated. 
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One interesting paradigm presented in the current literature suggests that the specificity of 
AhR ligands can lead to contrasting immunological outcomes. For instance, using an 
autoimmune disease mouse model, dioxin treatment was shown to be protective by 
promoting the generation of regulatory T cells (Treg) while FICZ treatment worsens disease 
scores by enhancing Th17 responses instead34,35. It is still unclear why dichotomy exists 















Figure 2. Some examples of AhR activating ligands found within the intestinal lumen. 
Numerous members of the bHLH/PAS protein family such as the hypoxia-inducible factors 
can function as environmental sensors.  As such, cell types localized to mucosal layers may 
utilize the AhR as a means to sense changes in the external environment across the 
epithelium, eliciting an appropriate response in return. An excellent illustration to support the 
above hypothesis was shown by Li and colleagues36, where a diet devoid of AhR ligands was 
found to reduce the number of intraepithelial lymphocytes in the mouse intestinal lamina 
propria (LP). In parallel, it was demonstrated that adult AhR knockout (KO) mice lacked 
intraepithelial lymphocytes in both the skin as well as the intestinal LP, exhibiting a 
functional requirement for AhR to promote the survival and function of these 
lymphocytes36,37. This phenomenon was also associated with a weakened mucosal barrier, 
increased bacteria load and heightened susceptibility to chemically induced colitis in AhR 
KO mice36. More recently, pigmented virulence factors such as pyocyanin or naphthoquinone 
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phthiocol derived from pulmonary pathogens like Pseudomonas aeruginosa and 
Mycobacterium tuberculosis respectively have been shown to activate the AhR1. The 
activation of AhR by these factors was demonstrated to drive cytokine and chemokine 
production that are thought to protect the host against bacterial insults1. The authors then 
conclude that the inability of AhR KO mice to defend against P. aeruginosa infection 
resulting in the histopathology detected within the lungs was attributed to the loss of a 
pathogen recognition receptor- the AhR1. Interestingly, the photoproduct of intracellular 
tryptophan (or FICZ) has been recently demonstrated to suppress inflammatory responses and 
ameliorate disease severity in a mouse model of Psoriasis, which was abrogated when AhR 
was absent38. Taken together, these findings suggest a strong association of AhR signalling in 
maintaining the homeostasis of mucosal surfaces, acting potentially as a sensor for changes in 
the external environment important for host defense and repair mechanisms.   
In further support of AhR’s participation in maintaining intestinal health, AhR signalling has 
been shown to be essential for the maintenance and function of IL-22 producing innate 
lymphoid cells in the LP39,40 as well as driving the postnatal development of isolated 
intestinal lymphoid follicles39,41. As expected, AhR KO animals were found to be highly 
susceptible to Citrobacter rodentium infection40, a likely consequence of the absence of 
innate lymphoid cells and IL-22 secretion by these cells. Notably, factors that negatively 
regulate the AhR pathway have been shown to down-regulate IL-1042 or IL-2243 production 
in T cells, a scenario that could help explain the pathogenesis of certain forms of 
inflammatory bowel diseases in human patients where AhR protein levels were found to be 
down-regulated44. Conversely, experimental colitis in animals was shown to be attenuated 
when AhR ligands were administered prior to the induction of colitis, due to the selective 
differentiation of Treg45 or as a result of heightened production of prostaglandin E2 in the 
colon upon AhR activation46. Interestingly, evidence from a recent study which has suggested 
that the human AHR gene may have gained a unique feature by selecting for microbial-
derived indoles as potent AhR agonists47, further bolsters the perception that AhR is central to 
promoting host-microbe commensalism and sustain intestinal immunity.   
Intestinal mucosal dendritic cells (DCs) and macrophages, which collectively are the major 
subsets of APCs present in the LP play a crucial role in both tolerance mechanisms as well as 
immunity against pathogens48,49. Intestinal APCs are specialized cell types that could sample 
luminal contents in a collaborative process, leading to the induction of tolerance toward fed 
antigens50.  While AhR expression is detected in APCs, its function in mucosal APCs and 
how the receptor and these sentinel cells could cooperatively sense the microenvironment to 
maintain intestinal homeostasis remains unexplored.  In the following chapter, I will 
introduce the major APC subsets found in the small intestinal LP, discuss their functional 
properties in addition to exploring the available literature on the role of AhR in APCs.  
1.3 MONONUCLEAR PHAGOCYTES IN THE GUT 
Phagocytic cells are abundant in the GI tract, poised to perform essential biological processes 
such as the clearance of apoptotic cells or for the sampling of antigens in the gut lumen. The 
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mononuclear phagocyte system (MPS), consisting of monocytes, macrophages and DCs 
contribute to a large proportion of these phagocytic cells found within the gut. Traditionally, 
these three groups of cells are classified under a single system under the notion that both 
macrophages and DCs were derived from a common monocytic precursor51. However, with 
recent evidences stemming from lineage tracing studies, the classification of these cells 
within the original MPS scheme requires some restructuring52. For example, it has been 
shown recently via genetic fate mapping or ‘cellular barcoding’ strategies that classical DCs 
are derived from a pool of common DC precursors of adult hematopoietic stem cell origins 
instead of monocytes as thought previously53,54. Further, CD11c integrin and MHCII 
complex, used as general markers for DCs are also found to be expressed by intestinal 
macrophages, rendering the use of these surface markers to identify functionally distinct APC 
subsets a serious challenge55,56. Following, efforts in classifying what is a DC or a 
macrophage by drawing inference from the literature is near impossible as investigators often 
categorize the cells of interest based on their perceived function, leading to further confusion 
among researchers. For instance, some may view CX3CR1+CD11c+ cells as DCs since they 
were found to extend transepithelial dendrites57,58 while others would consider them as 
intestinal macrophages due to their co-expression of macrophage markers such as CD6459. 
Nonetheless, the birth of a new classification method focusing on the developmental origins 
of these cells in combination with the identification of unique molecular factors that are 
crucial for the differentiation and/or maturation of specific subtypes may prove to be a step in 
the right direction52. 
For simplicity, I will classify the bona fide DCs as those that are dependent on Flt3L/Flt3R 
signalling that could either be CD11b positive or negative found within the small intestinal 
LP. Within the small intestinal LP DC populations, around 30% are known to express the 
gut-epithelial homing CD103 integrin in combination with CD11c and MHCII, as seen in 
close proximity with the intestinal epithelial barrier (Figure 3). Other DCs subsets in the SI 
LP include CD103−CX3CR1+CD11b+ DCs that can be further subdivided into CCR2 
expressing or non-expressing DCs60. Conversely, intestinal macrophages are largely derived 
from blood Ly6Chigh monocytes that extravasate into the tissue, differentiating into 
CD64+CX3CR1highF4/80high expressing tissue-resident macrophages61-63. A summary to show 
the various cell surface markers expression by monocytes, macrophages and DCs from the 
MPS system in the intestinal LP is presented in Table 1. 
Functionally, DCs from the small intestinal LP but not macrophages are known to be able to 
migrate to the regional lymph nodes, in this case, the mLNs via the up-regulation of CCR7 
expression to stimulate naïve T cells60,64. Interestingly, it has been shown that intestinal 
macrophages (CX3CR1high) are also capable of trafficking antigen from the LP into the mLN, 
albeit only during dysbiosis induced by antibiotics treatment65. The restricted migration of 
intestinal macrophages into the mLN was found to be myeloid differentiation primary 
response gene 88 (Myd88) signalling dependent65. Myd88 is an adapter protein involved in 
the downstream response of activated receptors of the toll-like receptor family, which 
recognizes a variety of bacterial-derived products (also known as pathogen associated 
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molecular patterns). The Myd88-dependent inhibition on antigen trafficking via intestinal 
macrophages therefore emphasizes the interaction between the resident microbes and its host 
to control unintended inflammation as a result of increased antigen presentation under steady-
state conditions65.  
©Johansson-Lindbom et al., 2005. Originally published in J. Exp. Med. doi: 10.1084/jem.20051100. 
Figure 3. Antigen presenting cells are found in the lamina propria and are close to the 
intestinal epithelial cells. Intestinal villus sections co-stained for CD11c in green (A), 
CD103 in red (B) and MHC II in red (C), showing the presence of both CD103+ antigen 
presenting cells (arrows pointing to CD11c+CD103+MHCII+ marked cells) within the lamina 
propria of the villus. 
The etiology of inflammatory bowel diseases (IBDs) has long been thought as a consequence 
of overt immune responses toward the otherwise harmless microbiota and food antigens.  In 
turn, mechanisms that are tailored to promote tolerogenic environment in the intestinal 
mucosa are highly desired in order for the GI tract to optimally perform its intended 
physiological functions. For example, CD103+ DCs isolated from both the LP and mLNs 
were found to be highly specialized in priming tolerogenic T cell responses via a retinoic 
acid-dependent manner to generate Foxp3+ Treg66,67. This functional specialization requires 
the expression of the aldehyde dehydrogenase 1a2 enzyme (ALDH1a2), which is involved in 
the conversion of dietary vitamin A to retinoic acid by CD103+ DCs67. CD103+ DCs in the 
LP and the mLN consists of either the CD11b+ or CD11b- populations as described earlier. 
Interestingly, both subsets when singly targeted for deletion were found to be redundant for 
both mLN and LP Treg populations68. A defect in the LP Treg numbers was only revealed 
when both subsets of CD103+ DCs were ablated simultaneously, possibly as a consequence 
of reduced ‘gut-tissue imprinting’ by these DCs, resulting in lowered expression of the gut-
homing receptor CCR9 on mLN Treg cells68.  Taken together, these data highlight the 
increased propensity of both CD103+ DCs in generating Treg over other DC populations and 
suggests redundancies in gut imprinting of newly generated Treg, possibly as a contingency 
plan to maintain tolerance in the LP. 
Even though the preferential generation of Treg is known to be driven by CD103+ DCs, the 
maintenance of regulatory T cell signature/Foxp3 expression in Treg was surprisingly 
dependent on the paracrine release of IL-10 from CD11b+ myeloid cells69. Correlating with 
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an earlier study70, these CD11b+ myeloid cells were postulated to be intestinal 
macrophages69. Following, another study suggested that oral tolerance induction and Treg 
expansion in the LP requires IL-10 secretion from intestinal CX3CR1+ macrophages71. 
Together, it seemed plausible that intestinal macrophages, similar to LP CD103+ DCs, adopt 
an immune-tolerant phenotype in the gut microenvironment and secrete high levels of IL-10 
to fortify the immune tolerant setting.    
 
Table 1. Cell surface expression levels of various known markers by different subsets of 
intestinal LP APCs. Table from “The monocyte-macrophage axis in the intestine” by Calum C. Bain and 
Allan McI Mowat is licensed under CC BY 3.0 
Of interest, a recent report has shown that CX3CR1+ macrophages in an IL-10 deficient 
environment acquired a pro-inflammatory phenotype and were found in high numbers in the 
mLN72, similar to what has been reported in animals with dysbiosis induced by antibiotics 
treatment65. When challenged with an intestinal pathogen (C. rodentium), CX3CR1+ 
macrophages in an IL-10 deficient background produced elevated levels of IL-23, which was 
positively correlated to increased mortality of infected mice73. It was later confirmed in both 
studies that intrinsic/autocrine IL-10R signalling in intestinal macrophages was crucial for the 
prevention of spontaneous and infectious colitis respectively but not IL-10 per se in the IL-10 
deficient background72,73.   
Through a concerted effort, intestinal DCs and macrophages play distinctive roles that shape 
the unique immune tolerant environment present in the intestines, important for oral tolerance 
induction and intestinal homeostasis. In addition, a recent study has provided novel evidence 
that oral tolerance induction requires intestinal DCs and macrophages to work 
cooperatively50. CX3CR1+ macrophages were demonstrated to send trans-epithelial dendrites 
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to first collect luminal antigens and then deliver these antigens through gap junctions to 
CD103+ DCs that subsequently migrate to the mLN to prime responding T cells50. Of note, 
these specialized functions of intestinal DCs and macrophages resulting in differential T 
helper cell responses were discovered to be dependent on mouse strain/housing conditions as 
well as gut regional localizations, highlighting the influence of extrinsic factors on APC 
functions74. In support of this, intestinal macrophages were found to interact with their 
immediate microenvironment, for example, with enteric neurons within the muscular layers 
and to acquire preferential tissue protective characteristics compared to their counterparts 
found within the LP75.    
The prospect of having the AhR, acting as an environmental sensor in intestinal APCs, fine-
tuning their effector functions in response to the dynamic microenvironment is therefore a 
likely event and a key interest of this thesis’s work. In the following sub-chapter, I will 
introduce some of the published findings on the role of AhR in DCs and macrophages.     
1.3.1 AhR in Antigen Presenting Cells 
1.3.1.1 AhR and Dendritic Cells 
Dendritic cells, given their ability to integrate signals from the environment via an array of 
innate PRRs and subsequent efficient activation of T cells, they are specialised to direct and 
orchestrate both innate and adaptive immune responses. DCs are a heterogeneous population 
of immune cells found in both lymphoid and non-lymphoid organs. Importantly, increased 
frequencies of non-lymphoid organ DCs are commonly found at host-environmental 
interfaces (the mucosal tissues) such as in the lungs, skin and gut surfaces76. Consequently, 
they are indispensable players in the maintenance of mucosal immune homeostasis77 and also 
in the establishment of oral tolerance as mentioned earlier78. A recent work targeting the 
deletion of MHCII specifically in classical DCs further supported the central role of these 
cells in maintaining homeostasis79. The lack of antigen presentation by classical DCs was 
found to induce chronic inflammation in the gut, which could be alleviated by antibiotics 
treatment or completely abolished in animals raised in germ-free conditions79, emphasising 
their role in maintaining host-microbe mutualism. Interestingly, the ablation of 
CD103+CD11b- but not CD103+CD11b+ DCs in the colon was shown to worsen the severity 
of experimental colitis, revealing functional differences between different DC subtypes 
during inflammation. With the identification of functional AhR in DCs80,81 and the reported 
roles of AhR functions in lymphocytes, we and others aimed to understand the role of AhR in 
DCs given their superior ability to modulate immune homeostasis.   
Notably, AhR activation via treatment with a non-toxic ligand has been shown to give rise to 
tolerogenic DCs that preferentially drive the differentiation of Foxp3+ Treg in vivo82 or inhibit 
Th17 expansion in vitro83. Accordingly, in the absence of AhR activation, the tendency of 
bone marrow derived DCs (BMDCs) in promoting Treg formation in co-culture experiments 
was significantly reduced as shown in a kynurenine-dependent pathway84. Also, BMDCs 
treated with dietary AhR ligands; I3C or Indirubin-3’-Oxime were found to alter their cell 
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surface marker expression levels and cytokine secretion profile85, a phenomenon that could 
be driven by the cross-talk between AhR and NF-κB signalling pathways86. In parallel, 
treatment of human monocyte-derived DCs with AhR ligands such as 2-(1′H-indole-3′-
carbonyl)-thiazole-4-carboxylic acid methyl ester or ITE was found to deliver similar 
effects87.  However, the results presented by various groups were not completely consistent. 
Maturation markers, for example, CD86 expression by BMDCs were increased in some 
studies86,88,89, but not in others upon AhR activation87,90. These discrepancies could be easily 
explained due to the use of different AhR ligands and hence we should exercise caution when 
interpreting the role of AhR in these cells when different types of ligands were used in 
experiments. Nonetheless, these studies highlighted the heterogeneity of AhR activation in 
DCs, dependent on the type of AhR ligands used and the source/subtype of DCs tested.  
An alternative way to study the role of AhR in DCs was to perform loss of function studies. 
Two independent groups had noted that DC-specific deletion of AhR partially abrogated the 
well-established immuno-suppressive effects of TCDD administration in animal models for 
lung infection91 and multiple sclerosis92. Taken together, the current literature supports the 
perception that AhR activation in DCs, in vitro and in vivo model systems, is needed for 
preventing hyper-reactive immune responses.        
1.3.1.2 AhR and Macrophages 
Macrophages are widely viewed as highly phagocytic cells that are important for clearing cell 
debris, engulfing bacteria and participating in tissue repair and remodeling mechanisms 
among other diverse functions. Investigations on the role of AhR in macrophage functions 
were relatively fewer however; data supporting its role in macrophages, important for host 
defense had already emerged. Using THP-1 (human monocytic cell line) cells and bone 
marrow-derived macrophages, the authors of one study demonstrated the need for AhR in 
macrophages to facilitate its activation upon exposure to IFNγ and M. tuberculosis1. The loss 
of this activation step was believed to be the cause of increased susceptibility to M. 
tuberculosis infection of AhR KO mice in the same study1. Subsequently, the discovery of 
pigments from M. tuberculosis (eg. naphthoquinone phthiocol) that could bind and activate 
the AhR led the authors to propose adding the AhR to the list of PRRs. Corroboratively, 
another study has reported the functional requirement for intrinsic AhR activity to promote 
the survival of macrophages, in addition to the production of reactive oxygen species by these 
cells to clear an intracellular bacteria- L. monocytogenes infection93. Interestingly, L. 
monocytogenes infection was found to induce higher levels of IL-6 and TNFα production by 
AhR-deficient macrophages, which correlates with the increased mortality of AhR KO 
animals upon the same infection93. The authors then concluded that AhR is essential for the 
suppression of pro-inflammatory cytokines secretion by macrophages while enhancing their 
survival and ability to kill bacteria93. In support of this, an overexpression of a pre-microRNA 
species that blocks the translation of ARNT (AhR’s dimerization partner) was found to 
reduce the suppression of pro-inflammatory cytokines by AhR activating ligands in 
lipopolysaccharide (LPS)-activated macrophages94. Together, it appears that AhR activating 
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signals restricts pro-inflammatory circuits in macrophages, similar to what has been reported 
thus far for AhR-mediated effects in DCs.  
Given the close proximity of LP APCs to the intestinal barrier, we became interested in the 
interactions between APCs and intestinal epithelial cells (IECs) in the context of maintaining 
mucosal homeostasis under steady-state conditions. Intestinal APC subsets were recently 
shown to participate in β-catenin/Wnt signalling pathways95, which is a major signalling 
pathway involved in regulating intestinal epithelial cell development and function. With 
evidences of cross talk between AhR and β-catenin/Wnt signalling pathways in various 
cellular contexts, we postulated that by deleting AhR specifically in intestinal APCs, we 
might reveal defects in epithelial barrier functions, as a consequence of Wnt signalling 
perturbations in APCs. In the next chapter, I will first introduce the role of IECs in innate 
immunity, followed by the reported interactions between IECs and intestinal APCs. A 
summary on intestinal epithelium differentiation and renewal with reference to AhR and/or 
APC mediated effects will also be presented.  
1.4 INNATE IMMUNITY: ROLE OF INTESTINAL EPITHELIAL CELLS 
The intestinal epithelial barrier (IEB), represented by only a single layer of cells has provided 
a niche for the exchange of ions, metabolites and dietary components among others across the 
epithelium. Hence, the IEB acts as the gateway for the myriad of signals originating from the 
lumen, which targets various aspects of host physiology, including critical biological 
processes such as shaping the mucosal immune system. The breakdown of the IEB results in 
unresolved inflammation over time and is one of the most prevalent causes of chronic IBDs, 
signifying the undisputed role of the IEB in regulating immune responses of the gut96.  
Apart from forming a physical barrier, the IEB constantly secrete factors to help keep the 
microbiota in check. The IEB is made up of mainly absorptive cells (enterocytes) but also 
contains in a salt-and-pepper fashion, numerous secretory cell types (Goblet cells, Paneth 
cells, Enteroendocrine cells and Tuft cells). Mucin-2 (Muc-2), a heavily glycosylated protein 
secreted predominately by goblet cells in both the colon and the small intestines forms an 
important extracellular matrix structure that prevents the invasion of microbes. Particularly in 
the colon, Muc2 participates in the formation of an inner denser mucus (devoid of microbes) 
and an outer domain, which is loose and allows the seeding of microbes97. It is believed that 
the outer layer mucus provides an ecosphere, with attachment sites for the microbiota, which 
consequently facilitate the selection of certain species of bacteria that could colonize the 
gut98. Genetic ablation of Muc2 expression in mice was shown to cause spontaneous colitis in 
addition to increasing the chance of these animals to develop tumors99. This underscores the 
protective role of epithelial-derived mucin against uncontrolled inflammation and 
tumorigenesis.  Other factors such as defensins and a C-type lectin (regenerating islet-derived 
protein III γ- Reg3γ) that provide bactericidal activities are mainly produced and secreted by 
the Paneth cells found at the base of small intestinal crypts. These Paneth-cell derived factors 
control the numbers as well as the composition of microbes by targeting conserved moieties 
of their outer membrane structural proteins. Of note, the production of these antimicrobial 
  13 
peptides can be increased via IL-22 or IL-17 signalling in IECs100. These cytokines are 
secreted by various mucosal LP immune cell subsets101 and shown to be important for the 
defense against pathogenic bacteria102.  
Recently, intrinsic activation via microbiota-derived signals in IECs were reported to be 
crucial for promoting IEC survival via the production of epidermal growth factor receptor 
ligands that may act in an autocrine loop103 or enhance IEC function by promoting the 
expression of tight junction proteins to maintain the IEB104. Of note, many of these responses 
are downstream of the Toll-like receptor (TLR) signalling pathways and together with other 
microbial recognition pathways, converge to enhance NF-κb activity in IECs105. Moreover, a 
breakdown interactions between these pathways were found to induce spontaneous colitis106 
or increase the susceptibility of mice to chemically induced colitis107. In summary, these 
findings underscore the significance of the interrelationships between the resident-microbes 
and IECs, critical for IEB function, homeostasis and repair.      
Apart from microbial-recognition pathways, recent findings have provided insights about 
normal physiological processes (in this case ER stress response), which when they are 
perturbed in IECs can lead to spontaneous enteritis108. The induction of ER stress intrinsically 
in IECs via the ablation of X-box-binding protein 1 (Xbp1) was shown to deplete 
differentiated Paneth cells and to a lesser extent, Goblet cells in the small intestines108. In 
general, it was noted that Xbp1 deletion in IECs increased their production of pro-
inflammatory cytokines and chemokines in response to TNFα or TLR5 agonist stimulation95. 
Of interest, hypomorphic variants of the XBP1 gene was found to confer a genetic risk for 
developing IBDs107. Additionally, in a follow up study, specific deletion of Xbp1 in Paneth 
cells was sufficient to induce spontaneous enteritis, leading the authors of the study to 
conclude that Paneth cells could serve as the initiation site for intestinal inflammation, 
implying a possible mechanism behind Crohn’s disease (CD)109. Surprisingly, the authors did 
not find any changes to IEB permeability in IEC-specific Xbp1 KO animals, suggesting that 
permeability changes is not a prelude to inflammation in this context108. Nonetheless, these 
findings indicate that a defective response of the IECs to stimuli from the local environment 
can result in disease.  
In support of the above, molecular factors targeting the AhR signalling pathway in IECs were 
recently shown to modulate intestinal inflammation110,111. In one of the two studies 
conducted, an inverse relationship between microRNA-124 and AhR protein levels was noted 
when analyzing colonic samples from active CD patients110. Subsequently, miRNA-124 was 
found to negatively regulate AhR protein translation and its overexpression could exacerbate 
experimental colitis110. Conversely, in another study, AhR activation in IECs via FICZ 
treatment was found to reduce IEC-derived IL-7, ameliorating inflammation induced by 
dextran sodium sulphate (DSS)111. Taken together, it appears that AhR functions as an 
environmental sensor in IECs, where its activation limits IEC response to inflammatory 
signals, promoting tolerance.      
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1.4.1 Intestinal Epithelium and Mucosal Antigen Presenting Cells Cross Talk 
Besides creating separate domains (inside versus outside), the intestinal epithelium also 
participates in generating efficient immune responses at highly specialized sites such as the 
Peyer’s patches (PP) or isolated lymphoid follicles. Consequently, the epithelium at those 
sites is commonly referred to as follicular-associated epithelium (FAE). Under steady state 
conditions, Microfold (M) cells represents approximately 10% of all epithelial cells found 
within the FAE, a specialized cell type for the phagocytosis and transcytosis of luminal 
antigens across the epithelium to be captured by APCs in the underlying lymphoid follicle112. 
This process of antigen sampling, through M cells has been shown to be critical for 
generating immune-tolerant IgA responses toward the commensal microbiota113. The antigen 
sampling by the intestinal epithelial has long thought to be restricted to M cells however, it 
has been shown recently that small intestinal Goblet cells could also assist in antigen 
sampling by transferring soluble antigens to CD103+ DCs directly114. Although the functional 
significance of these two distinct routes of antigen entry mediated by the epithelium remains 
unclear, it is evident that the IEB cooperates with sub-epithelial APCs to prime adaptive 
immune responses, implying a key role for their interaction in intestinal immune homeostasis.    
In the presence of commensal microbiota, the intestinal epithelium plays an important role in 
inducing tolerance. Epithelial-derived factors such as TGF-β1, TSLP and retinoic acid (RA) 
are secreted in response to microbiota-derived signals and were found to imprint dendritic 
cells in the intestinal lamina propria, instructing them to drive Treg responses over other T 
helper cell subsets in the draining lymph nodes105,115. Corroboratively, migratory DCs 
isolated from the mLNs were found to induce higher levels of Treg compared to DCs isolated 
from the spleen in an RA and TGF-β1 dependent manner as mentioned earlier66,67. 
Importantly, the activation of retinoic acid receptors on T cells up-regulates their expression 
of CCR9, allowing them to migrate towards the gut upon leaving the lymph nodes. Thus, the 
conditioning of DCs via IEC-secreted factors, which indirectly instructs the gut homing of 
activated T cells, is essential for inducing tolerance in gut mucosal tissues.  
While these studies highlight an active interaction between mucosal DCs and the intestinal 
epithelium in response to environmental factors, DC-dependent effects acting on the 
intestinal epithelium is much less understood.  
1.4.2 Intestinal Epithelium Differentiation and Renewal 
The intestinal epithelium is one of the most regenerative organ of the body, requiring only an 
estimated three to five days for the whole epithelium to be replaced with fresh cells 
orientating from the crypt bottom, in mice (Figure 4). This remarkable feat is accomplished 
through the presence of a stem cell niche at the base of the crypt where intestinal stem cells 
(ISCs) expressing the Leu-rich repeat-containing G protein-coupled receptor 5 (Lgr5) can be 
found sandwiched by Paneth cells, in the small intestines. These Lgr5+ ISCs (also known as 
crypt base columnar cells) can undergo continuous cell cycling for self-renewal and to give 
rise to daughter cells, which go on to repopulate the gut epithelium at regular intervals. This 
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rapid turnover program is usually tightly regulated, but can be disrupted during pathological 
conditions where signalling pathways governing ISC proliferation and differentiation are 
perturbed, leading to inflammation109,116 and/or tumorigenesis108,117-119. Of note, energy 
deprivation as a result of calorie restriction has been shown to enhance ISC function, 
emphasizing the responsiveness of the ISC niche to the dynamic microenvironment120.  
Taken together, the intestinal epithelium and its characteristic high turnover rate are well 
suited to respond swiftly to a wide array of insult and also changes in physiological 
requirements.  
Broadly categorized into absorptive and secretory cell types, IECs can be further subdivided 
into five different mature subtypes. The over-arching signalling mechanisms that regulate 
Lgr5+ ISC maintenance versus proliferation and/or differentiation into different subtypes rely 
mostly on two signalling pathways: Wnt signalling and Notch signalling119. While activation 
of both signalling cascades are crucial in maintaining the ‘stem-ness’ of a Lgr5+ ISC, the 
differentiation programs of progenitors may reflect a disparity in preference for the two 
pathways. For instance, a Notch target gene, Hes-1, activates genes involved in the 
differentiation of precursors into the absorptive lineage while suppressing secretory cell-type 
specification by down-regulating Math-1121. In contrast, Wnt signals activates Math-1 
expression, and in conjunction with other transcription factors, contribute to the 
differentiation of progenitors into one of the four known secretory lineages122,123. 
Interestingly, a recent study found that by suppressing Wnt signalling simultaneously, one 
could block the significant expansion of Math-1+ secretory cells caused by Notch signalling 
blockage124. These data suggests that a constant re-balancing of morphogenic pathways is 
necessary for the full functioning of the gut epithelium. Of note, the reduction of Dkk1 (a 
Wnt antagonist) expression was found to increase IEC proliferation, mainly in the colon and 
enhanced recovery upon DSS induced colitis125. However, these mice also developed 
abnormal crypt architecture coupled with hyper proliferation of IECs during epithelial 
restitution in response to the injury125. This emphasizes the need for a delicate fine-tuning of 
well-balanced signals for intestinal epithelial homeostasis and repair.    
Not until recently, most in vitro studies involving IECs were performed on transformed cell 
lines or cells derived from human colorectal adenocarcinomas. In 2009, Sato T., et al 
showcased a robust method to culture primary intestinal epithelium in a three-dimensional 
matrix derived from a single FACS sorted Lgr5+ ISC126. That was just two years after the 
discovery of Lgr5 as a marker for ISCs in both the small intestines and the colon127.  The 
elegance of this ex vivo system is that one could observe, in real time, the transformation of a 
single ISC into an organoid containing numerous budding structures that resemble individual 
crypts in vivo. In essence, it is now possible to study the differentiation of IECs, from 
committed precursors into mature differentiated cell types. Targeting various signalling 
pathways or genetically ablate or overexpress genes, techniques that were technically 
challenging and time consuming to perform in vivo could now be simplified. Following we 
harnessed the benefits of this technique to establish a co-culture system to study the 
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interaction of mucosal DCs (with or without AhR signalling) with the intestinal epithelium 












Figure 4. Movement of progenitor cells up the crypt-villi axis is a continual process. 
Adapted by permission from Macmillan Publishers Ltd: Nature Reviews Genetics 7, 349-359, copyright (May 
2006) 
Non-cell autonomous effects of Paneth cells was recently demonstrated to influence ISC 
biology120, suggesting that cell types that are in close association with the intestinal 
epithelium may similarly respond to signals from the environment, in turn affecting IEC 
function. Apart from immune cells and mesenchyme cells, cellular components of the enteric 
nervous system (ENS) were found to be in close association with the intestinal epithelium (in 
the villi and areas surrounding the crypt). In the next chapter, I will introduce the ENS 
briefly, followed by how the ENS contributes to intestinal barrier functions and immunity.   
1.5 THE ENTERIC NERVOUS SYSTEM 
The ENS is known to have extensive control over physiological processes such as GI 
motility, fluid secretions, the local control of blood flow as well as mucosal immune system 
regulation. Primarily, the ENS is arranged into two concentric plexuses namely the myenteric 
plexus (MP) and the submucosa plexus (SMP). The MP is ‘sandwiched’ between the 
longitudinal muscle and circular muscle layers while the SP is found within the submucosa 
layer as shown (Figure 5). The intrinsic nervous system of the gut (ENS) also receives inputs 
from the CNS by both sympathetic (via celiac ganglion) and parasympathetic pathways 
(vagus nerve), hence may also act as the gateway for the brain-gut axis.  
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Being the largest component of the peripheral nervous system with neuronal numbers 
matching those that are found within the spinal cord, the ENS earns itself the title of the 
‘second brain’128. The ENS is composed of both neurons and glial where glial cells were 
reported to be outnumbering the enteric neurons at a ratio of 4:1 or higher129. A tissue 
preparation of the longitudinal muscle and myenteric plexus (LMMP) revealed multiple 
ganglia consisting of neuronal cell bodies in close contact with enteric glial cells (EGCs). 
Each ganglion could also be seen interconnected by inter-ganglionic connectives (Figure 6 
and Figure 7). In addition to their primary locations within the plexuses, nerve fibres and glial 









Figure 5. Locations of the myenteric- and the submucosa plexus found within the gut 
wall. By Goran tek-en [CC BY-SA 3.0 (http://creativecommons.org/licenses/by-sa/3.0)], via Wikimedia 
Commons. https://upload.wikimedia.org/wikipedia/commons/3/31/Layers_of_the_GI_Tract_english.svg 
The development of the ENS (in mus musculus) starts with the delamination of a subset of 
vagal neural crest cells from the neural tube at around E8.5, which later invade the foregut 
mesenchyme at around E9.0-E9.5. Upon entry, these cells now designated enteric neural crest 
cells (ENCCs) migrate in a rostro-caudal direction to colonise the whole gut, a process which 
is completed by around E15-E15.5132. Of note, sacral neural crest cells also contribute, albeit 
at lower levels compared to vagal neural crest contributions. Sacral neural crest cells colonise 
the hindgut in a caudal to rostral direction starting from the colon at around E13.5133. Of note, 
the survival, proliferation and migration of these ENCCs are essential for the completion of 
the developing ENS. Molecularly, the expression of receptor tyrosine kinase RET, SRY-box 
10 (Sox10) transcription factor and G protein coupled receptor- endothelin receptor B 
(Ednrb) in migrating ENCCs were discovered to be vital for their survival and timely 
migration throughout the GI tract during embryogenesis134. As such, genetic perturbations in 
these genes and their associated signalling pathway components can lead to varying degrees 
of aganglionosis, which is a failure of ENCCs to completely colonise the whole GI tract, 
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Figure 6. The Myenteric Plexus. Neuronal cell bodies and choline acetyltransferase (ChAT) 
positive fibres are labelled in blue (HuC/D) and red (ChAT+) respectively while EGCs are 
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Figure 7. A closer look into individual ganglia of the myenteric plexus. Neuronal cell 
bodies are labelled in blue (HuC/D). Neuronal fibres stained in red are visualised with 
antibodies against Tuj1 (A) or ChAT (B). EGCs are labelled in green via Sox10 nuclear 
staining  (A) or S100β immuno-staining revealing glial fibers (B).  
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In human patients, aganglionosis often occurs in the distal region of the gut and can be easily 
identified at birth due to the presence of congenital megacolon, commonly known as the 
Hirschsprung’s disease. Other intestinal motility disorders such as slow transit constipation 
and intestinal pseudo-obstruction where subtle defects in ENS functionality were found 135,136 
also underscores the importance of having a fully functional ENS for intestinal health.  
Recently, the roles of the ENS in controlling intestinal inflammation have been described, 
providing evidences for bidirectional communication between the intrinsic nervous system of 
the gut and intestinal immune cells, which is in the interest of this thesis. In the subsequent 
chapters, I will cover some of the recent advances in our understanding of how the ENS can 
modulate intestinal immune functions. Topics on how our resident microbiota influences the 
function of the ENS will also be discussed.   
1.5.1 Role of ENS in mucosal immunity 
In recent years, our understanding of how the gut-brain axis can modulate inflammatory 
responses has only begun to take flight. The seminar study conducted by Tracey and 
colleagues137 had demonstrated the capacity of vagus nerve stimulation (VNS) on dampening 
immune responses upon LPS challenge in vivo, paving the way for many studies thereafter. 
Since then, several studies have demonstrated an increased sensitivity of vagotomised 
animals to models of intestinal inflammation, such as those induced by DSS 138-140. Notably, a 
recent paper has provided the mechanistic evidence of how VNS could control post-surgery 
intestinal inflammation (post-operative ileus - POI), independent from VNS effects on the 
spleen or T cells.141 The authors showed that the activation of α7 nicotinic acetylcholine 
receptor (α7nAChR) expressed by intestinal resident macrophages mediated via VNS could 
reduce the levels of pro-inflammatory cytokines such as IL-6 and IL-1β detected in the 
muscularis externa after POI induction141. The same study concluded by proposing that the 
anti-inflammatory effects of VNS on surgery-induced intestinal inflammation was an indirect 
consequence through the actions of cholinergic neurons of the myenteric plexus acting on 
resident macrophages141. In parallel, an earlier study showed that the activation of cholinergic 
myenteric neurons by 5-HT4R agonists could protect against POI by inducing the release of 
acetylcholine from these neurons that acts on α7nAChR expressed by macrophages to inhibit 
pro-inflammatory responses142. Conversely, intestinal inflammation was found to be 
associated with changes to the chemical nature of myenteric neurons143 or increased 
activation of enteric glial cells144. Taken together, these findings highlight the constant 
dialogue between the ENS with inputs from the central nervous system among others to 
regulate immune functions of the gut.    
An increasingly important aspect in understanding human physiology is the study of the less 
human, our resident microbiota. Recent advances in the field of host-microbe interactions 
have uncovered many unanticipated properties of microbes for example, the putative ability 
of the microbiota in regulating anxiety-like behaviour of experimental organisms145,146. 
Whether these observations are linked to direct or indirect mechanisms originating from the 
luminal microbiota remains to be determined. An interesting feature of the ENS and its 
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constituents is that, PRRs such as TLRs commonly expressed by immune cells are also 
expressed by enteric neurons and EGCs147. Therefore, it is plausible that the ENS, with its 
vast organisation of neurons and glia cells covering areas including the mucosal layers, could 
respond directly to microbiota-derived signals. Indeed, some evidences in support of the 
above have been reported in the literature. In particular, TLR4 KO mice or mice with specific 
deletion of Myd88 in neural crest cell derivatives were shown to harbor reduced nitrergic 
neurons and exhibit delayed GI motility148. The authors also note that mice housed in germ-
free conditions presents similar phenotypes when compared to TLR4 KO mice, implying a 
role for the microbiota in regulating GI motility through TLR4 signalling148. A plethora of 
studies lending their support for the above findings where changes related to the microbiota 
and/or diet, consequently modulating intestinal transit have been reported149-153. Although the 
exact mechanisms on how the diet-microbial axis could perform this intricate act remains 
inconclusive, some evidence points towards the involvement of the TLR signalling148 and/or 
GDNF/RET151,154 signalling pathways within the ENS in addition to energy availability 
derived from the diet149,152. Interestingly, the literature also provides some evidence where the 
effects of microbiota on ENS development was shown to present itself as early as 3 days 
postnatally155. Together, it seems that the ENS is highly plastic and matures alongside 
environmental cues from the microbiota and/or diet-derived signals after birth.      
1.5.1.1 Bidirectional communication between the ENS and the immune system 
Intestinal muscularis macrophages (MM), located within the smooth muscle layers were first 
described more than 20 years ago156 and subsequently thought to interact with neurons at the 
layer of the MP to modulate immune responses in the gut156,157. Indeed, two recent findings 
have confirmed the interactions between enteric neurons and MM where their crosstalk was 
found to be important for controlling intestinal motility158 or immune protection of the ENS 
in the context of an infection75. In the first study, the authors identified enteric neurons as the 
source for colony stimulating factor 1 (CSF-1), a factor crucial for the development of MM 
while bone morphogenetic protein 2 (BMP2), which was shown to activate the BMPRII 
signalling pathway in enteric neurons was found to be expressed by MM reciprocally158. In 
addition, BMP2 supplementation was shown to rescue the hyper-contractility reported in MM 
depleted mice, confirming the role of BMP2 produced by MM in regulating intestinal 
motility158. Interestingly, the reported communications between the two cell types (neuronal 
and immune cell) in controlling intestinal motility was also found to be microbiota-
dependent158. Specifically, in antibiotics treated mice and in LPS-stimulated primary enteric 
neurons, BMP2 expression by MM was reduced and CSF-1 production from cultured 
primary enteric neurons was increased respectively158, highlighting the previously unreported 
interaction between the two cell types driven by the resident microbiota. In the second study, 
it was revealed that upon bacterial infection, extrinsic sympathetic fibers innervating the gut 
muscularis were rapidly activated75. This swift neuronal response was coupled with the 
activation of β2-adrenergic receptors expressed by MMs that further reinforced its steady 
state tissue-protective phenotype, a phenomenon that was identified when the authors 
compared the gene-expression profiles of isolated MMs with LP macrophages75. The authors 
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then conclude that the autonomic response towards an intestinal pathogen may be important 
for the preservation of the integrity of the ENS against any inflammation-induced tissue 
damage75. Of note, the exact mechanisms activating the enteric neurons (intrinsic or extrinsic) 
by bacteria in these contexts remain unclear.  
Analogous to microbiota driven effects on host responses as illustrated above, recent findings 
also shed light on the consequences of ENS defects on microbiota diversity and composition 
159,160. These studies were based on a mouse model of Hirschsprung’s disease where the 
Ednrb gene was mutated in both alleles, leading to colonic aganglionosis at birth161,162. In 
addition to the skewed microbiota diversity in mutant animals, the authors of one of the two 
studies reported an increased risk for enteroinvasion by E.coli and impaired mucosal defence 
159. Of interest, the defective control of mucosal inflammation in TLR-2 KO mice was found 
to correlate with impaired Ret-GFRα1 signalling, which is important for maintaining the 
neuro-chemical coding and architecture of the ENS. Following, administration of exogenous 
glial cell-derived neurotrophic factor or GDNF (the ligand for Ret-GFRα1 signalling) was 
shown to restore the ENS defects and ameliorate chemically induced colitis in these TLR-2 
KO mice when compared to untreated controls. Taken together, these findings underscores 
the inter-dependencies between the microbiota, the ENS and the immune system.    
1.5.1.2 Interplay between the Enteric Glia Cells and the Intestinal Epithelium in Intestinal 
Inflammation   
A relatively new functional unit coined as the gut-vascular unit, critical for inhibiting the 
systemic dissemination of unwanted materials such as microbes has been recently described 
163. In that report, it was postulated that the EGCs, together with pericytes that surrounds the 
endothelial cells form the gut-vascular unit, a similar cellular setup compared to the blood 
brain barrier in the CNS163. Increasingly, EGCs have been at the focus of understanding the 
role of ENS components in regulating intestinal immunity in addition to maintaining the 
integrity of the intestinal epithelial barrier131,164,165.  Based on transcriptomic analysis166, co-
culturing of IECs with EGCs was found to induce the expression of genes related to 
differentiation and cell adhesion but repressed the expression of genes related to immunity 
and cell proliferation in IECs. At present, at least four different EGC-derived factors that 
could regulate IEC biology (differentiation and proliferation among others), consequently 
regulating intestinal barrier functions have been identified167-170. Of interest, S-
nitrosoglutathione, one of the four glial-derived factors mentioned has been reported to block 
the down-regulation of ZO-1 expression by IECs during Shigella flexneri infection, reducing 
bacteria entry and lessening the lesions caused by the infection. In summary, these findings 
emphasize the role of EGCs in reinforcing the intestinal epithelial barrier, thus participating 
in the maintenance of intestinal homeostasis.  
As mentioned earlier, the expression of various TLRs have been confirmed in EGCs, 
suggesting that these cells could respond directly to microbiota-derived signals147,171. For 
example, in a Myd88-dependent fashion, EGCs were found to induce NO production by 
secreting S100β, contributing to inflammation171,172. These results indicate a role for the 
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microbiota in directly regulating immune functions of EGCs. However, under steady 
conditions, it is not clear whether the microbiota has a role in the homeostatic regulation of 
EGCs (Paper II). 
Of interest, EGCs were found to express the major histocompatibility class II (MHC II) 
molecule, albeit only in inflamed areas of CD patients and barely detectable in healthy 
controls173. Following, as several lines of evidence suggest, EGCs can ‘turn on’ their antigen 
presentation potential at the onset of inflammation or during infections171,174,175, indicative of 
a role for EGCs in controlling inflammation. In support, two independent studies have shown 
that targeted deletion of EGCs can lead to spontaneous fulminant jejuno-ileitis176 or 
enterocolitis analogous to human necrotizing enterocolitis177, highlighting the remarkable 
immune-protective function of EGCs in the intestinal mucosa. Additionally, similar to 
astrocytes in the CNS, EGCs can be identified via their expression of the glial fibrillary acidic 
protein (GFAP)178, where increased GFAP expression is associated with EGC activation144. 
Interestingly, the levels of GFAP in addition to GDNF were found to be differentially 
regulated when comparing patients suffering from ulcerative colitis to patients with CD179. 
The disparity between the reported levels of GFAP and GDNF in different IBD types may 
provide insights into the pathogenesis of chronic inflammatory disorders where EGCs plays a 
central role. 
Using the expression of GFAP and the S100-calcium binding protein180 to identify EGCs, a 
huge quantity of these cells can be found forming dense glial networks at the base of the 
crypts, including the mucosa, in both the small intestines and the colon130,181 (also in paper 
III). Of interest, recent work by Bohorquez, D. V. and colleagues has demonstrated a direct 
physical association between EGCs with enteroendocrine cells (which are rich in vesicles 
containing hormones that regulate appetite and consumption), suggesting a role for EGCs in 
hormonal control182. Of interest, microbiota derived metabolites were recently shown to 
regulate serotonin biosynthesis in enteroendocrine cells183,184, raising the possibility of an 
indirect effect of microbes acting on EGCs via epithelial cell types185. In summary, these 
discoveries uncover the existence of intricate relationships between EGCs and the intestinal 
epithelium still largely unexplored. For example, what is the physiological importance of 
EGCs found at the base of the crypts compared to those found deep into the mucosa (within 
the villi LP)? 
In this thesis, we explored the highly dynamic interactions of various biological systems, with 
each other and/or with the external environment, using specific aims as presented on the next 
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2 AIMS 
The overall aim of this thesis was to examine the interrelationships of different biological 
systems when interacting with the external environment, including the resident microbiota to 
maintain intestinal homeostasis. The GI tract was the organ of choice for our studies since 
multiple biological systems are in close association with one another, in addition to being 
constantly challenged with the myriad of signals emanating from the intestinal lumen.  
Specific aims for each paper:  
• Paper I – To study the role of an environmental sensor, the AhR in antigen presenting 
cells in the context of maintaining intestinal homeostasis and controlling inflammation.   
 
• Paper II – To investigate the role of the microbiota in the homeostatic regulation of 
enteric glial cell networks.  
 
• Paper III – To establish a stable co-culture system to uncover the significance of enteric 


















3 METHODOLOGICAL HIGHLIGHTS 
3.1 MICROFLUIDICS BASED GENE EXPRESSION PROFILING 
During the course of our work, FACS sorted intestinal APC subsets (per mouse) yielded 
insufficient numbers for a microarray type study. Fortunately, we came across a new ‘chip’, 
which allowed us to perform qRT-PCR based assays with a pre-selected set of genes using 
much less starting material. The chip required minute volumes per sample, at 5µl, due to its 
architecture that operates using microfluidics-based technologies186. A total of 48 or 96 
samples can be loaded onto each chip (depending on the type of chip used). These samples 
will then be individually mixed with 48 or 96 gene-expression assays of choice in segregated 
micro-chambers on the chip. This means that one could compare the relative expression of at 
least 48 genes from one sample to the other 47 samples tested in one go. We managed to 
interrogate the relative expressions of 48 genes of interest among distinct intestinal APC 
subsets and across biological groups using this method. Of note, introducing air bubbles 
while manually loading samples and/or assay reagents could destroy the whole setup process. 
The priming (mixing of samples and assay reagents, guiding them into their respective micro-
chambers) of the chip is done automatically via a machine. Importantly, there are two issues 
to note when using this technique. First, the approach is biased and one might miss interesting 
differences due to the pre-selection criteria. Second, a pre-amplification step for each cDNA 
sample, using the primers designed for all 48 genes of interest needs to be performed. 
Assuming that amplification efficiencies for each specific amplicon are different, one should 
not compare the relative expression of selected genes within the same cell. Nonetheless, it is 
still a powerful technique for comparing between groups, when sample volumes are scarce. 
3.2 GERM-FREE ANIMALS 
The germ-free (GF) model is currently one of the most powerful techniques employed to 
study the interrelationships between microbes and its host. The title of ‘germ-free’ refers to 
animals that are raised in a completely sterile environment, devoid of all other 
microorganisms such as bacteria, viruses and fungi. The concept of a GF model is attributed 
to Louis Pasteur more than a century ago, although he believes that life cannot flourish 
without the presence of microorganisms. Indeed, it took a number of years before germ-free 
colonies (rats) could be setup, due to the lack of knowledge on diet supplementation. 
Vitamins B and K needs to be added in the diet for example, as they will be lost in the 
absence of microbes. Apart from nutritional supplements, another major challenge was to 
keep animals GF, without any contamination. Current technologies utilize clear plastic 
isolators, where in-flow of air is sterile filtered and all materials such as bedding and cages 
were autoclaved before use. Additionally, frequent tests for bacteria growth in fecal 
homogenates are done to ensure that colonies remain GF. 16s PCR testing are also 
occasionally carried out to identify any non-cultivable bacteria that were present.  
The derivation of germ-free mice starts with performing cesarean sections on full term 
mothers and deliver the pups, still in the uterine sac, into the plastic isolators after passing 
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through antiseptics to be resuscitated and cared for by GF foster mothers. An advantage of 
this method is that it allows researchers to derive his/her genetically modified animals as GF, 
to study the interactions between the microbiome and the gene of interest. Alternatively, 
researchers can also mono-colonize or introduce a group of known microbes into GF animals, 
giving rise to gnotobiotic (‘known life’ in Greek) animals to question the role of a particular 
species and/or composition of bacteria. Importantly, experiments should not start right after 
derivation into GF conditions as the first litter came from a mother that was not GF and hence 
were all exposed to microbial influence during in utero development.  
Anatomically, GF mice are very different from conventionally raised animals. Most notably, 
the caecum of GF mice can be as big as 4-8 times compared to their conventionally raised 
counterparts, due to the accumulation of undigested fibers. In addition to anatomical 
differences, various defects in the development, metabolism and the immune system of GF 
animals have been reported187. Hence, disease phenotypes associated with GF conditions 
could also be seen as secondary consequences due to the absence of microbes. In such cases, 
wide-spectrum antibiotics are often used to decipher the direct roles of the microbiota.  Still, 
the GF model remains a key tool in demonstrating the intricate involvement of our resident 
microbiota in our daily lives, spurring further on-going mechanistic studies. 
3.3 TISSUE-SPECIFIC REPORTER MOUSE LINES 
To perform tissue-specific ablation of a gene of interest, most researchers rely on the Cre-lox 
system. The Cre enzyme is capable of performing site-specific recombination by recognizing 
short target sequences known as loxP sites. Depending on the orientation of loxP sequences, 
the Cre enzyme can either excise the sequence sandwiched between two loxP sequences in 
tandem (Figure 8A) or catalyse the inversion of sequences flanked by two loxP sites (‘flox-
ed’) that are in opposite orientations (Figure 8B).  Cre expression can be restricted to specific 
tissues (or cell types) by the use of tissue-specific promoters/enhancer elements. 
For temporal control of Cre activity (especially useful if a gene of interest was found to be 
embryonically lethal when deleted constitutively), the Cre enzyme was ‘re-engineered’ to 
fuse with a mutant form of the human estrogen receptor (also known as the CreERT2 
transgene), keeping the recombinase from entering the nucleus upon its translation in the 
cytoplasm. Only when tamoxifen is administrated, the engineered protein would be able to 
translocate into the nucleus to perform its intended function in a timely fashion. 
Apart from deleting genes temporally via scheduled injections of tamoxifen, reporter 
constructs can be introduced instead to perform lineage-tracing studies at specific time points. 
The R26R-Confetti multi-colored construct is one such example (Figure 9). The R26R-
Confetti multi-colored reporter was first used in conjunction with a heterozygous mouse 
carrying the CreERT2 transgene, under the control of Lgr5 promoter/enhancer elements, to 
study the dynamics of ISC function in maintaining the intestinal epithelium188. The design of 
the construct was adapted from an earlier work (Brainbow 2.1), which encodes for four 
fluorescent proteins derived from jellyfish189. The process of excision and/or inversion of the 
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floxed reporter alleles are stochastic and random, where labeling efficiencies are dependent 
on the dose of tamoxifen given.  
During our studies, we combined the R26R-Confetti allele with mice heterozygous for 
Sox10::CreERT2, allowing us to stochastically label peripheral glial cells with one of the 4 






















Figure 9. R26R-Confetti transgene. Stochastic action by the CreERT2 enzyme dependent on 
tamoxifen induction can generate 4 possible colours from the multi-coloured reporter. nGFP- 
nuclear GFP. mCFP- membrane-tethered CFP. The expression of RFP or YFP is cytosolic as 
shown. pA- poly-A tail.  
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4 RESULTS AND DISCUSSION 
This thesis represents a compilation of three papers that in a concerted manner, examines the 
dynamic interactions between different biological systems of the host with the external 
environment. The first paper focuses on an environmental sensor and its function in sentinel 
cells such as the mucosal APCs, important for intestinal innate immunity and homeostasis. 
The second paper investigates the enteric glial cell network post-natally and how this process 
is regulated by the presence of microbiota. Finally in the third paper, we proceeded to set up a 
co-culture system to study the interaction between intestinal epithelial cells and enteric glial 
cells in a three dimensional matrix.   
4.1 PAPER I: ABLATING THE ARYL HYDROCARBON RECEPTOR (AHR) IN 
CD11C+ CELLS PERTURBS INTESTINAL EPITHELIUM DEVELOPMENT 
AND INTESTINAL IMMUNITY 
The involvement of AhR signalling in various autoimmune and chronic inflammatory 
diseases has been shown in the context of AhR KO mice34,40,45. We were interested to 
examine if the loss of AhR specifically in intestinal APCs could modulate the disease 
progression of a well-established acute colitis model. To achieve this, we proceeded to obtain 
a mouse line with specific deletion of AhR in the intestinal APCs. We crossed the AhRfl/fl 
mice generated by the laboratory of Dr. Christopher A. Bradfield190, which is available at 
Jacksons’ Laboratory with another mouse line expressing Cre-recombinase under the control 
of the CD11c promoter. The CD11c driver for Cre-recombinase was selected since both 
intestinal DCs and macrophages constitutively express CD11c, allowing us to delete AhR in 
both populations simultaneously. After a few rounds of crossings, we maintained our 
intestinal APC-specific AhR KO mouse line by crossing AhRfl/fl; CD11c::Cre+/- with AhRfl/fl; 
CD11c::Cre-/- animals to generate equal proportions of experimental (11cAhR-/-) and control 
(11cAhR+/+) mice. RT-PCR data generated from FACS sorted populations of various DC and 
macrophage subsets from the LP showed efficient depletion of AhR expression only in Cre+ 
(11cAhR-/-) animals. 
Exposed to 2% DSS in their drinking water, we found that the experimental group (11cAhR-/-) 
was more susceptible to the chemically induced colitis, losing significantly more bodyweight 
and displayed enhanced colon shortening compared to the control group. In addition, we 
found increased levels of acute phase proteins expression in the liver of the 11cAhR-/- group 
when compared to the control, suggesting an inadequate resolution of inflammation locally 
that resulted in systemic effects. Interestingly, we did not find any significant difference when 
we compared the T-cell specific AhR KO mice with controls for bodyweight loss and colon 
shortening at end point, suggesting that the increased sensitivity of AhR KO mice is mainly 
due to the loss of AhR signalling in intestinal APCs.  
Epithelial injury is believed to be the initiation step to colitis induction in the DSS model. 
Following, we suspected that in the absence of AhR in APCs, abnormalities in the epithelium 
might already be present under steady state conditions. Intestinal APCs were known to 
participate in Wnt/β-catenin signalling pathway for tolerance induction95 and hence we 
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decided to screen the intestinal epithelium for changes, in the Wnt/β-catenin signalling 
pathway in hopes to reveal any defects in intestinal epithelium morphogenesis. Motivated by 
our findings, where increased Wnt target genes expression was found in the ileal epithelium 
of 11cAhR-/- animals, we went on further to perform more sensitive assays such as in situ 
hybridization with specific probes to detect possible differences in the composition of cell 
types in the intestinal epithelium. Our data revealed that in the absence of AhR in CD11c+ 
cells, the number of Olfm4+ ISCs and Goblet cells were increased but Cryptdin4+ Paneth cells 
were reduced in these mice. These findings were of huge interest to us for three reasons. (1) 
These changes raises the possibility that intestinal APCs could participate in lineage decisions 
of differentiating IECs, possibly as another example for non-cell autonomous effects acting 
on ISC function reported earlier120. (2) Our data presented here are in line with previous 
publications where ISC numbers and Wnt target genes expression were often up regulated 
when Paneth cells were lost or defective117,118. (3) Were these effects observed a direct or an 
in direct consequence of the loss of AhR signalling in APCs?  
To test for direct effects, we pooled FACS sorted intestinal migratory APCs from the mLN of 
11cAhR-/- or 11cAhR+/+ mice and co-cultured these cells with isolated small intestinal crypts 
from AhRfl/fl mice for a period of 5 days in vitro. The APCs from the mLN were chosen as 
isolating adequate numbers of APCs from the lamina propria was technically challenging and 
we also reasoned that the majority of CD11c+MHCIIhigh cells in the mLN were CD103+ DCs 
that migrated into the lymph nodes from the LP under steady state conditions. We found that 
organoids co-cultured in the presence of AhR-deficient DCs (DCAhR-/-) when compared to 
those grown in the presence of AhR-sufficient DCs (DCAhR-/-) expressed reduced levels of all 
secretory cell type markers, including the master transcription factor for secretory cell type 
specification: Math-1. Interestingly when we increased the ratio of DC: Crypts seeded at the 
start of the co-culture from 1:1 to 5:1, we found that the expression of Sox9, a transcription 
factor important for Paneth cells was reduced while the marker for goblet cells (Muc2) was 
increased in the DCAhR-/- group compared to the ‘no’ DC group (organoids without the 
addition of DCs). These results were in agreement with the in vivo data obtained earlier 
whereby reduced numbers of Paneth cells but increased numbers of goblet cells were 
observed in the 11cAhR-/- mice. Notably, in all scenarios tested, we did not find any changes in 
the levels of Lgr5 expression, suggesting that the AhR-DC axis-dependent effects did not 
affect the ISC population. Also worth mentioning, the ‘no’ DC group control revealed DC 
specific effects, for example, organoids grown in the presence of DCs were found to express 
higher levels of ChgA, a marker for enteroendocrine cells. Taken together, our data indicate a 
role for AhR signalling in guiding IEC lineage specification via intestinal APCs.     
Next, we questioned if there were any intrinsic defects in intestinal APCs due to the loss of 
AhR signalling, resulting in alterations of cell signalling pathways that could affect IEC 
specification. From the literature, intestinal DCs and macrophages can be further subdivided 
into various groups as discussed in the introduction of this thesis. In this paper, we tried to 
sort out different subtypes as best as we could, grouping intestinal APCs broadly into three 
groups namely, CD103+CD11b- DCs, CD103+CD11b+ DCs and CD103-CD11b+F4/80+ 
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macrophages. Similar to earlier studies where activation of AhR signalling in BMDCs was 
shown to modulate cell surface expression of conventional markers88-90, the loss of function 
of AhR in our study was associated with a general decrease in all three conventional markers 
analyzed (CD103, CD11b and CD11c). These alterations in cell surface markers expression 
suggest functional changes in AhR-deficient DCs, prompting us to investigate the gene 
expression profiles of the three major APC subsets identified here. Indeed, with a selection of 
genes that we analyzed, Wnt7a and Dkk3 were amongst the list of genes that were 
differentially regulated when AhR was absent in intestinal APCs. Although we found that 
AhR-deficient APCs also expressed lower levels of tolerance-related genes such as TGF-β1, 
ALDH1a2 and IL-10, we did not detect any significant differences in inflammatory T cells in 
the LP of 11cAhR-/- mice compared to the controls. However we did find a significant increase, 
at two-fold of CD4+IFNγ+ T cells in the mLN of 11cAhR-/- mice. Future work on the effects of 
AhR activation or inhibition in distinct APC subsets, paying particular attention to the 
regulation of the Wnt/β- catenin pathway, which consequently affects IEC biology, may be of 
great interest.  
In summary, we uncovered an unexpected role for AhR in regulating intestinal epithelium 
morphogenesis through the deletion of AhR in intestinal APCs. The well-described 
environmental sensor, the AhR, recently coined as a pathogen recognition receptor was 
befitting1, given its expression in sentinel cells of the mucosa (the intestinal APCs) that in 
turn coordinates innate immune responses required to maintain intestinal homeostasis.  
4.2 PAPER II: MICROBIOTA CONTROLS THE HOMEOSTASIS OF GLIAL 
CELLS IN THE GUT LAMINA PROPRIA 
As the general interest of our lab was to study host-microbe interactions, we became 
interested to find out if the nervous system of the gut responds to microbiota-derived signals. 
In the second paper, we studied the relationship between a subpopulation of EGCs that is 
found within the mucosa, with the intestinal microbiota. EGCs are a heterogeneous group of 
cells, with at least four distinct subtypes based on their morphological appearances131,191. 
Mucosal EGCs (mEGCs) can be found within the LP, forming extensive networks starting 
from the level of the crypts and all the way up into the villus-tips130,181, making several 
contacts with mucosal tissues such as the epithelium, neurites and endothelial cells181,182. We 
began by tracing the formation of these intricate networks starting from embryonic stage (E) 
16.5. To our surprise, immunostaining of intestinal sections at E16.5 revealed that S100β+ 
EGCs were not detected in almost all the villi examined. In contrast, among all the villi that 
we studied, approximately 50% of them were positive for neurites that arises from the enteric 
ganglia. This trend was found to be similar at postnatal day (P) 0 however, the number of 
EGCs found in the LP along the villus-crypt (VC) unit increased significantly to ~32% from 
near zero by P10. The percentage of EGC+ VC units, along with the appearance of two or 
more EGC per VC unit was found to increase further until adult stages (8-12 weeks). To 
investigate the potential effects of weaning on the homeostasis of EGCs, we setup two groups 
of animals (of various ages) for comparisons.  The first group of animals was weaned for 7 
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days prior to sample collection, with ages P27, P32 and P38 (post-weaning group) while the 
second group consists of those that stayed with their mothers till ages P18, P21 and P27 (pre-
weaning group). We found that the number of mEGCs quantified within the pre-weaning 
group was significantly lower when compared to the post-weaning group. Interestingly, we 
also noted that the numbers from the pre-weaning group and the post-weaning group were 
comparable to those recorded for P10 and adult animals respectively. Furthermore, when we 
compared the two animals of the same age (P27) derived from the two different groups, their 
numbers was found to be significantly different, which suggests that the increase of mEGCs 
detected over time were not subjected to ‘age’ per se, but a factor of the weaning process. 
Taken together, our results indicate that the development of the mEGC network is not 
complete at birth and responds to signals associated with the postnatal environment and 
changes in nutrition.  
Given the dynamic nature of the mEGC network, we reasoned that what we had observed 
might represent only a snapshot of a constant flow of mEGCs, possibly derived from sources 
such as the MP and/or the SMP within the intestinal wall. To test this hypothesis, we 
combined the Sox10::CreERT2 transgene, which allows for the specific expression of Cre 
recombinase in peripheral glial cells upon tamoxifen induction192, with a mouse carrying the 
Cre-dependent multicolor R26R-Confetti reporter188 to perform lineage tracing studies to 
track EGCs at stipulated time points. Four days after tamoxifen induction (T0), we analyzed 
the tissues to determine the baseline labeling efficiency of EGCs in adult mice. At T0, most 
confetti+ EGCs were located in the ganglionic plexi of the MP and the SMP while only ~18% 
of VC units analyzed contained mostly single color labeled EGCs. Next, we analyzed the 
tissues derived from T15 and T90, which is 15 days and 90 days post induction to follow the 
fate of labeled EGCs. Although the labeling intensity of EGCs within the MP and SMP 
remained largely similar at T15 and T90, huge numbers of labeled EGCs were detected 
within the LP of the VC unit, at ~72% and ~65% of all VC units examined respectively. 
Interestingly, at both time points (T15 and T90), labeled EGCs detected within the VC units 
were represented by different confetti colors compared to the single colored EGCs seen at T0, 
suggesting that EGCs in the VC units were derived from multiple linearly unrelated EGC 
sources coming from the ganglionic plexi. Further, when we used an alternative driver 
(hGFAP::CreERT2) for inducible Cre expression in a relatively smaller subset of EGCs192, 
similar data were obtained. Together, our lineage-tracing strategy has revealed a constant 
replenishment of mEGCs, possibly originating from plexuses of the outer intestinal wall, 
contributed by Sox10+ and GFAP+ glial cells.          
Given that the mEGC network develops substantially upon weaning, which coincides with 
the period where the complexity of intestinal microbiota increases and matures193, we went 
on to investigate the prospective connection between these two events by quantifying the 
number of EGCs in GF mice and compare that to their conventionally raised (CONV) 
counterparts. Although we did not find any significant difference between the EGC numbers 
within the two major plexuses when comparing between the two groups, the mean and 
density of mEGCs detected in GF mice was found to be significantly lower than their CONV 
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controls. The reduction in numbers was seemingly restricted to EGCs within the villi, and 
less so for EGCs that were at the level of the crypts. To probe if the microbiota driven 
development of the mEGC network had critical developmental windows, we 
conventionalized GF animals (CONV-D) at 4 weeks of age and harvested the intestinal 
tissues at 8 weeks of age for comparisons. When compared to the GF mice, the mean and 
density of EGCs in the villi of CONV-D animals were found to be at levels usually seen for 
CONV animals, suggesting that the microbiota controls EGC migration and this process is 
not restricted to early postnatal developmental periods.  
Given that EGCs are plastic by nature191 and possess the ability to respond to the presence of 
the microbiota, we questioned if the maintenance of EGCs within the villi is dependent on 
functional host-microbe interactions. Adult mice aged 8-12 weeks were treated with 
antibiotics for a period of 3 weeks and thereafter the intestinal tissues were collected and 
immunostained for the S100β marker. Our results revealed a significant reduction of S100β+ 
cells within the villi of mice treated with antibiotics compared to untreated controls. 
Similarly, using the inducible lineage tracing protocol described earlier, we found that 
antibiotics treatment interfered with the homeostatic migration of EGCs into the villi, 
significantly reducing the number of multi-colored EGCs in the villi at T15 compared to 
untreated controls. Taken together, our experiments indicate that signals originating from the 
microbiota are crucial in initiating, in addition to sustaining the centripetal flow of EGCs 
from the peripheral plexi into the LP.     
In conclusion, we have disclosed a previously unappreciated centripetal movement of EGCs 
into the mucosa from the peripheral plexi, initiated and controlled by microbiota-derived 
signals. Of interest, EGCs are known to express receptors that recognize bacterial products 
such as LPS or are in close contact with the intestinal epithelium. The exact mechanisms of 
how the microbes dictate the out-ward movement of EGCs and the functional significance of 
such a migration during health and disease remains to be investigated.  
4.3 PAPER III: ESTABLISHING A CO-CULTURE SYSTEM TO STUDY ENTERIC 
GLIAL CELL FUNCTIONS. 
We hypothesized that EGCs are responding to extrinsic signals emerging from the resident 
microbiota via various direct or in-direct mechanisms185. For example, the intestinal 
epithelium may secrete chemo-attractants upon activation by microbiota-derived signals, 
leading to the migration of EGCs into the villi. In order to examine the interactions of EGCs 
with the intestinal epithelium further, we began by setting up in vitro cultures of primary 
EGCs, to be used later for co-cultures with IECs.  
As described in the Introduction section of this thesis, the MP is sandwiched between the 
outer longitudinal muscle layer and the inner circular muscle layer. Thus, upon enzymatic 
digestion of the longitudinal muscle layer with the MP attached underneath, we were able to 
grow EGCs in culture using previously published methods144,191. Capitalizing on a genetic 
labeling technique (by combining Sox10::CreERT2 transgene with R26R-tdTomato reporter), 
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EGCs can be visualized directly in culture, simplifying efforts to compare different culture 
conditions to define an optimal protocol to expand and maintain EGCs. In both culture 
conditions that we had tested (serum-free versus serum-positive culture conditions), 
tdTomato+ EGCs were readily identified, which were also positive for other known EGC 
markers such as GFAP178, S100β194 and Foxd3195. Surprisingly, when we analyzed the 
number of tdTomato+ cells that were labeled with 5-ethynyl-2’-deoxyuridine (EdU) after a 
short exposure, we found that serum-free conditions gave rise to a higher proportion of 
proliferating (EdU+tdTomato+) cells at 3 days in vitro (DIV3). Further, serum-free conditions 
also gave rise to higher proportions of tdTomato+ cells that co-expressed Sox2, a marker 
commonly associated with stem cell-like characteristics. Taken together, it appeared that 
primary EGCs grown in serum-free conditions exhibited a more proliferative potential at 
DIV3. 
Subsequently, we followed our cultures, comparing conditions with or without the use of 
serum as before till DIV6. We found reciprocal effects on the expression of Sox2 and S100β 
in tdTomato+ cells, dependent on the culture conditions used. The proportion of tdTomato+ 
cells that were Sox2+ and S100β+ in serum-positive conditions was significantly lower and 
higher compared to serum-free cultures respectively. Additionally, we also noted a significant 
number of DAPI+ cells that were positive for α-smooth muscle actin (α-SMA) in serum-
positive cultures while much less were detected in serum-free cultures. Of interest, S100β 
expression has been associated with the loss of progenitor-like characteristics of GFAP+ cells 
within the CNS196. Taken together, our data suggests that serum free conditions favor the 
maintenance of progenitor-like characteristics and were less permissive for the growth of 
αSMA+ fibroblasts.   
Apart from molecular differences detected in differentially cultured EGCs, their 
morphological appearances were also found to be largely different. GFAP immunostaining 
revealed smaller cell sizes in serum-free cultures compared to serum positive conditions. 
Moreover, EGC colonies in serum-free conditions were more widespread (individual cells 
were further apart) while EGCs in serum-positive conditions formed tight colonies. 
Importantly, these phenotypic morphologies and cell ‘placements’ were found to be 
reversible, by switching culture conditions from serum-free to serum-positive and vice versa. 
Our data are in line with previous reports where EGCs were found to be highly plastic and 
exhibit heterogeneity in their morphologies in vivo191. Interestingly, we found that passaging 
cells grown in serum-free conditions resulted in the formation of neurosphere-like bodies (a 
ball of cells made up of progenitors, neurons and glia cells), suggesting that such culture 
conditions may favor the maintenance of progenitor cells in vitro. 
As serum-free conditions gave rise to highly proliferative EGCs with less contamination from 
other cell-types in culture, we followed this protocol for the expansion of primary ECGs in 
subsequent co-culture experiments. Given that the established protocol for culturing intestinal 
organoids differs from that of EGCs, we first tested if EGCs can be maintained in organoid-
culture conditions. We found that primary EGCs derived from our initial expansion protocol 
  33 
required the addition of soluble factors from a commercially available basement membrane 
extract (Matrigel©) when cultured in organoid base-media, which includes growth factors 
specific for intestinal organoids. These observations raises interesting questions on the effects 
of factors commonly found in Matrigel© and/or growth factors that were added specifically 
for organoid growth, which may modulate EGC functions.   
Finally, in three-dimensional co-cultures where intestinal organoids and EGCs were 
embedded in the basement membrane matrix, we observed close associations of EGCs with 
intestinal organoids, indicative of an active communication between the two cell types. We 
also noted different types of associations, for example, EGCs could be seen wrapping around 
organoid structures and cell debris or appeared to be in contact with a single cell on the 
organoid surface. With recent evidences describing physical contacts between specific 
subtypes of IECs (enteroendocrine cells) with EGCs, it remains to be investigated if what we 
had observed is reminiscent of their interactions in vivo.   
In summary, we have established a workflow for the development of an ex vivo system to 
study the interaction of EGCs with the intestinal epithelium at near physiological conditions. 
We believe that the benefit of such a system lies in the possibility of including other cell 
types such as immune cells and/or myofibroblast commonly found in the same anatomical 
location, allowing more physiologically-relevant experiments to be conducted.   
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5 CONCLUDING REMARKS AND PERSPECTIVES 
In the first paper, we studied the functions of AhR specifically in intestinal APCs. Arguably, 
the AhR itself has been a topic of interest, given its highly evolutionary conserved nature. 
Homologues of the mouse/human AhR can be found in much simpler multicellular organisms 
such as C.elegans where a role for AhR in neuronal development has been described197. 
Following, it is thought that the AhR acquired the ability to respond to environmental factors 
as a result of adaption to participate in the modulation of different aspects of organismal 
biology as we have discussed here. Apart from AhR’s well-known functions in xenobiotic 
metabolism, its involvement in immune system regulation has garnered a lot of attention 
lately. The great interest in this area could be related to the ascribed functions of the intestinal 
microbiota in shaping our mucosal immune system’s development and function. Microbial-
derived metabolites were reported to be putative ligands for the AhR and the survivability of 
certain innate lymphoid cells, among others, dependent on intrinsic AhR signalling supports 
this hypothesis. Also, various planar polycyclic hydrocarbons can bind the AhR, and the 
downstream effects may reflect subtle differences in the conformational changes induced by 
the binding of different ligand types. Perhaps it is due to the fact that AhR appears to have 
differing functions in different cell types and/or contexts depending on the type and 
availability of ligands. My ‘gut’ feeling about the importance of AhR in biology is that it is 
not involved in ‘all or none’ responses but rather, a factor that tilts the tide of a battle between 
two or more activating signalling pathways. This is not hard to accept as the complete AhR 
KO mice are viable and breeds normally in general, albeit with some developmental defects 
as reported previously. An example could be taken from the response of AhR-deficient 
BMDCs to LPS stimulation. Without any challenge, both WT and AhR-deficient BMDCs did 
not secrete detectable levels of IL-10. However, when stimulated (with LPS), AhR-deficient 
BMDCs produced significantly less IL-10 compared to WT controls84. This may be an 
explanation as to why defects in AhR-/- mice were very subtle and only surfaces when 
challenged with insults. Similarly, in our study, phenotypic changes detected in AhR-
deficient DCs and the associated abnormalities in the intestinal epithelium of 11cAhR-/- mice 
were not immediately apparent (no spontaneous colitis detected) but these data gave us a 
strong indication of perturbations in the absence of AhR in CD11c-expressing cells. 
Moreover, our results suggest that intestinal APCs could modulate IEC differentiation 
program via AhR signalling, which is an interesting topic to be studied further in detail. Of 
note, AhR signalling in IECs was recently reported to be protective against chemically 
induced colitis42, suggesting a role for intrinsic AhR activation in IECs during an 
inflammatory insult. Taken together, it seems that the AhR functions in concert with many 
other signalling pathways, providing an informed-input to assist the host/cell in deciding 
which biological stance, for example, to activate or remain dormant in response to 
environmental cues. 
Every organism has to interact closely and adapt to changes within its environment. The 
functional significance of such interactions can be exemplified by the development of chronic 
inflammatory disorders in the presence of ‘friendly’ gut microbiota or diet-related compounds 
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such as gluten in genetically susceptible individuals. The ENS is well known for controlling 
various aspects of GI functions, including the modulation of mucosal immunity and IEB 
permeability. In our second study, the centripetal flow of a cellular component of the ENS, 
the EGCs were found to be both initiated and maintained by the resident microbiota. Our 
findings highlight the plasticity of the ENS in responding to signals originating from the 
lumen. Questions remain on the functional requirements for the migration and maturation of 
EGC networks deeper into the mucosa where abundant microbes are found immediately 
across the epithelium. Of interest, mEGCs were reported to be in close contact with several 
mucosa tissue types in the same anatomical location, such as endothelia cells, IECs and 
possibly immune cells. Drawing parallels from recent findings that the microbiota play a 
central role in controlling blood brain barrier permeability after birth198, EGCs may respond 
to the presence of microbes and assist in the maintenance of the gut-vascular barrier163 to 
prevent the entry of microbes and/or antigens into the blood stream. In addition, 
heterogeneity exists among the pool of EGCs in the gut as mentioned, where at least four 
different EGC subtypes were classified through their distinct morphological phenotypes. 
Interestingly, most of the ‘microbiota sensitive’ EGCs were largely Type III mEGCs131,191 
(based on their morphologies), suggesting a specific role for this EGC subtype in responding 
to luminal bacteria. However, whether these differences translate into discrete functions for 
various EGC subtypes remain to be investigated. Moving forward, advanced methodologies 
based on single-cell expression data and bioinformatics might provide the missing link to 
understanding the functions of distinct EGCs subtypes, in relation to gut homeostasis.  
The intestinal epithelium represents a vital barrier to safeguard the host by forming a physical 
and biochemical separation away from the external environment. We have found that an 
environmental sensor, in combination with sentinels of the mucosal immune system 
(intestinal APCs), can modulate the composition of IEC subtypes under steady state 
conditions. The dynamic nature of the intestinal epithelium is well poised to adjust to changes 
in the microenvironment as a consequence of, for instance, a change in diet or dysbiosis 
caused by a recent infection and/or lifestyle–related alterations. The constant replenishment 
program of the intestinal epithelium depends heavily on the highly proliferative ISCs found at 
the bottom of each crypt.  The area immediately around the ISCs constitutes the intestinal 
stem cell niche. Besides Paneth cells, immune cells and myofibroblasts, ENS components 
were also found in close association with intestinal crypt structures, possibly playing a role in 
the maintenance of the stem cell niche and consequently ISC function. The continuous 
interplay between different biological systems indicates that not one system interacts with the 
environment alone. Each system is under the influence of one another, dependent on the 
wide-array of activating environmental cues. Looking forward, there is a need to develop 
methods that could study the complex interrelationships between different systems at near-
physiological states to understand the combinatorial outcomes upon exposure to 
environmental signals.  Intestinal epithelial organoid co-cultures with other cell types of 
interest, in combination with the use of microfluidics based-organ chips199 may open up new 
avenues toward that goal. 
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